Breast-conserving treatment: Controversies and consensus

Journal of Surgical Oncology

Volumn 62, Issue 3, 1996, Pages 228-234

  Noguchi, Masakuni ^a   Kinne, David W ^b   Miyazaki, Itsuo ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b Columbia University ^*  (United States)

Author keywords

axillary dissection; breast conserving therapy; patient selection; radiation

Indexed keywords

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; HUMAN; LYMPH NODE DISSECTION; PARTIAL MASTECTOMY; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RISK FACTORS;

EID: 0030037674     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199607)62:3<228::AID-JSO16>3.0.CO;2-2     Document Type: Review

References (107)

1. National Institute of Health Consensus Conference: Treatment of early-stage of breast cancer. JAMA 265:391-395, 1991.
2. Bartelink H, Van Dam F, Van Donegan J: Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys 11:381-385, 1985.
3. Schain E, Edwards B, Gorrell CR, et al.: Psychosocial and physical outcomes of primary breast cancer therapy: Mastectomy vs. excisional biopsy and irradiation. Breast Cancer Res Treat 3:377-382, 1983.
4. Lasry JCM, Margolese RG: Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. 69:2111-2115, 1992.
5. Mueller CB: Lumpectomy: Who is eligible? Surgery 100:584-585, 1986.
6. Jenkins PL, May VE, Hughes LE: Psychological morbidity associated with local recurrence of breast cancer. Int J Psychiatry Med 21:149-155, 1991.
7. Harris JR, Recht A: Conservative surgery and radiotherapy. In Harris JR, Hellman S, Henderson IC, Kinne DW (eds): Breast Diseases. 2nd Ed. Philadelphia: JB Lippincott, 1991, p388-419.
8. Recht A: Patient selection for treatment with conservative surgery and radiation therapy. Cancer Invest 10:471-476, 1992.
9. Winchester DP, Cox JD: Standards for breast-conservation treatment. CA Ca J Clin 42:134-162, 1992.
10. Veronesi U, Volterrani F, Luini A, et al.: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26:671-673, 1990.
11. Veronesi U, Banfi A, Salvadori B, et al.: Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial. Eur J Cancer 26:668-670, 1990.
12. Veronesi U, Luini A, Vecchio MD, et al.: Radiotherapy after breast-conserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591, 1993.
13. Holland R, Veling SHJ, Mravunac M, et al.: Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979-990, 1985.
14. Lesser ML, Rosen PP, Kinne DW: Multicentricity and bilaterality in invasive breast cancer. Surgery 91:234-240, 1982.
15. Clark RM, Wilkinson RM, Miceli PN, et al.: Breast cancer. Experiences with conservative therapy. Am J Clin Oncol 10:461-468, 1987.
16. Recht A, Connolly JL, Schnitt SJ, et al.: Conservative surgery and radiation therapy for early breast cancer: Results, controversies, and unresolved problems. Semin Oncol 13:434-449, 1986.
17. Bartelink H, Borger JH, van Dongen JA, et al.: The impact of tumor size and histology on local control after breast conserving therapy. Radiother Oncol 11:297-303, 1988.
18. Pearl RM, Wisnicki J: Breast reconstruction following lumpectomy and irradiation. Plast Reconstr Surg 76:83-86, 1985.
19. Berrino P, Campora E, Santi P: Post-mastectomy breast deformities: Classification and techniques of surgical correction. Plast Reconstr Surg 79:567-572, 1987.
20. Matory WE, Wertheimer M, Love S: Partial mastectomy: Technical considerations in achieving cosmesis. Breast Dis 5:225-233, 1992.
21. Noguchi M, Taniya T, Miyazaki I, et al.: Immediate transposition of a latissimus dorsi muscle for correcting a quadrantectomy breast deformity in Japanese patients. Int Surg 75:166-170, 1990.
22. Noguchi M, Saito Y, Mizukami Y, et al.: Breast deformity; its correction, and assessment of breast conserving surgery. Breast Cancer Res Treat 18:111-118, 1991.
23. Noguchi M, Minami M, Earashi M, et al.: Oncologic and cosmetic outcome in patients with breast cancer related with wide excision, transposition of adipose tissue with latissimus dorsi muscle, and axillary dissection followed by radiotherapy. Breast Cancer Res Treat 35:163-171, 1995.
24. Danoff B, Goodman RL: Identification of a subgroup of patients with breast cancer in whom conservative surgery and radiation is contraindicated. Int J Radiat Oncol Biol Phys 11(suppl 1):104, 1985 (abst).
25. Recht A, Danoff BS, Solin LJ, et al.: Intraductal carcinoma of the breast: Results of treatment with excisional biopsy and irradiation. J Clin Oncol 3:1339-1343, 1985.
26. Noguchi M, Earashi M, Kinoshita K, et al.: A case with breast cancer under the nipple who underwent breast conserving treatment. Breast Cancer 1:157-160, 1994.
27. Fisher B, Redmond C, Poisson R, et al.: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989.
28. Clark RM, McCulloch PB, Levine MN, et al.: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683-689, 1992.
29. Fisher B, Anderson S, Fisher ER, et al.: Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338:327-331, 1991.
30. Kantorowitz DA, Poutler CA, Rubin P, et al.: Treatment of breast cancer with segmental mastectomy alone or segmental mastectomy plus radiation. Radiother Oncol 15:141-150, 1989.
31. Kurtz JM, Jacquemir J, Amalric R, et al.: Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65:1867-1878, 1990.
32. Solin LJ, Fowble B, Martz K, et al.: Results of re-excisional biopsy of the primary tumor in preparation for definitive irradiation of patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 12:721-725, 1986.
33. Recht A, Silver B, Schnitt S, et al.: Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. Int J Radiat Oncol Biol Phys 11:1271-1276, 1985.
34. Schnitt SJ, Connolly JL, Khettry U, et al.: Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 59:675-681, 1987.
35. Schmidt-Ullrich R, Wagner DE, Terulla O, et al.: Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early breast carcinoma. Int J Radiat Oncol Biol Phys 17:733-738, 1989.
36. Harris JR, Recht A, Schnitt S, et al.: Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast. Breast Cancer Res Treat 5:245-255. 1985.
37. Zafrani B, Vielh P, Fourguet A, et al.: Conservative treatment of early breast cancer: Prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term results. Eur J Cancer Clin Oncol 25:1645-1650, 1989.
38. Boyages J, Recht A, Connolly JL, et al.: Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19:29-41, 1990.
39. Kurtz JM, Jacquemier J, Amalric R, et al.: Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 8:591-598, 1990.
40. Eberlein TJ, Connolly JL, Schnitt SJ, et al.: Predictors of local recurrence following conservative breast surgery and radiation therapy: The influence of tumor size. Arch Surg 125:771-777, 1990.
41. Jacquemier J, Kurtz JM, Amalric R, et al.: An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 61:873-876, 1990.
42. Lindley R, Bulman A, Parson P, et al.: Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery 105:13-20, 1989.
43. Stotter AT, McNeese MD, Ames FC, et al.: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64:2217-2225, 1989.
44. Calle R, Vilcoq JR, Zafrani B, et al.: Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 12:873-878, 1986.
45. van Limbergen E, van de Bogaert W, van der Schueren E, et al.: Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 8:1-9, 1987.
46. Recht A, Connolly JL, Schnitt SJ, et al.: The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radial Oncol Biol Phys 14:3-10, 1988.
47. Kurtz JM, Spitalier JM, Amalric R, et al.: Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys 15:271-276, 1988.
48. Miller A, von Fournier D, Kaufmann M, et al.: Whole breast irradiation and boost irradiation in breast conserving therapy based on morphologic findings. Breast Dis 2:121-130, 1989.
49. Osteen RT, Connolly JL, Recht A, et al.: Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg 122:1248-1252, 1987.
50. Harris JR. Connolly JL, Schnitt SJ, et al.: The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation. Ann Surg 201:164-169, 1985.
51. Chabon AB, Goldberg ID, Venet L: Carcinoma of the breast: Interrelationship among histopathologic features, estrogen receptor activity and age of the patients. Huma Pathol 14:368-372, 1983.
52. Holland R, Veling SHJ, Mravinac M, et al.: Histologic multifocality of TIS, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer 56:979-990, 1985.
53. Fisher ER, Sass R, Fisher B, et al.: Pathological findings from the National Surgical Adjuvant Breast Project (Protocol No.6). Intraductal carcinoma (DCIS). Cancer 57:197-208, 1986.
54. Fletcher GH: Clinical dose of response curves of human malignant epithelial tumours. Br J Radiol 46:1-12, 1973.
55. Fletcher GH: Subclinical disease. Cancer 53:1274-1284, 1984.
56. Clarke DH, Le MG, Sarrazin D, et al.: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985.
57. Chu AM, Cope O, Russo R, Lew R: Patterns of local-regional recurrence and results in stages I and II breast cancer treated by irradiation following limited surgery. Am J Clin Oncol 7:221-229, 1984.
58. Kinne DW: Conservation surgery for breast cancer: Selection criteria and technical considerations. Surg Today, Jpn J Surg 24:767-771, 1994.
59. Schnitt SJ, Connolly JL: Processing and evaluation of breast excision specimens: A clinically oriented approach. Am J Clin Pathol 98:125-137, 1992.
60. Ghossein NA, Alpert S, Barba J, et al.: Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 127:411-415, 1992.
61. Lagios M, Richards V, Rose M, et al.: Segmental mastectomy without radiotherapy: Short-term follow-up. Cancer 52:2173-2179, 1983.
62. Fisher ER. Saas R, Fisher B, et al.: Pathological findings from the National Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57:1717-1724, 1986.
63. Vicini FA, Eberlein TJ, Connolly JL, et al.: The optimal extent of resection for patients with stage I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 214:200-204, 1991.
64. Carter D: Margins of "lumpectomy" for breast cancer. Hum Pathol 17:330-332, 1986.
65. Macmillan RD, Purushothan AD, Mallon E, et al.: Breast-conserving surgery and tumour bed positivity in patients with breast cancer. Br J Surg 81:56-58, 1994.
66. Frazier TG, Wong RWY, Rose D: Implications of accurate pathological margins in the treatment of primary breast cancer. Arch Surg 124:37-38, 1989.
67. Noguchi M, Minami M, Earashi M, et al.: Intraoperative histologic assessment of surgical margins and lymph node metastases in breast-conserving surgery. J Surg Oncol 60:185-190, 1995.
68. Noguchi M, Minami M, Earashi M, et al.: Pathologic assessment of the surgical margins on frozen and permanent sections in breast conserving surgery. Breast Cancer 2:27-33, 1995.
69. Liligren G, Holmberg L, Adami H-O, et al.: Sector resection with or without postoperative radiotherapy for stage I breast cancer: Five-year results of a randomized trial. J Natl Cancer Inst 86: 717-722, 1994.
70. Hand R, Sener S, Imperato J, et al.: Hospital variables associated with quality of care for breast cancer patients. JAMA 266:3429-3432, 1991.
71. Lazovich D, White E, Thomas DB, et al.: Under utilization of breast-conserving surgery and radiation among women with stage I or II breast cancer. JAMA 266:3433-3438, 1991.
72. Recht A, Houlihan MJ: Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. Ann Surg 222:9-18, 1995.
73. Fisher B, Redmond C, Fisher ER, et al.: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985.
74. Hayward JL, Caleffli M: The significance of local control in the primary treatment of breast cancer. Arch Surg 122:1244-1247, 1989.
75. Senofsky GM, Moffat FL Jr, Davis K, et al.: Total axillary lymphadenopalhy in the management of breast cancer. Arch Surg 126:1336-1342, 1991.
76. Moffat FL Jr, Senofsky GM, Davis K, et al.: Axillary node dissection for early breast cancer: Some is good, but all is better. J Surg Oncol 51:8-13, 1992.
77. Fentiman IS, Mansel RE: The axilla: Not a no-go zone. Lancet 337:221-223, 1991.
78. Gaglia P, Bussone R, Caldarola B, et al.: The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol 23:849-854, 1987.
79. Lee YT, Cahn LS: Surgical treatment of carcinoma of the breast. II. Prognostic factors influencing relapse rate. J Surg Oncol 25:102-108, 1984.
80. Fisher B, Bauer M, Wickerham DL, et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52:1551-1557, 1983.
81. Lythgoe JP, Palmer MK: Manchester regional breast study -5 and 10 years results. Br J Surg 69:693-696, 1982.
82. Cancer Research Campaign Work Party: Cancer Research Campaign (King's/Cambridge) trial for early breast cancer, Lancet 2:55-60, 1980.
83. Bismar B, Ljungdahl I: Postoperative lymphedema after treatment of breast cancer. Act Chir Scand 149:687-691, 1963.
84. Kissin MW, Querci della Rovere G, et al.: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-585, 1986.
85. Marzeron JJ, Otemzguine Y, Huart J, et al.: Conservative treatment of breast cancer: Results of management of axillary lymph node area in 3353 patients. Lancet 2:1387, 1985.
86. Rosen PP, Lesser MT, Kinne DW, et al.: Discontinous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 197:276-283, 1983.
87. Noguchi M, Taniya T, de Aretxabala X, et al.: The significance of regional lymph node dissection in the surgical management of breast cancer. Jpn J Surg 19(1):21-28, 1989.
88. Veronesi U, Rilke F, Luini A, et al.: Distribution of axillary node metastases by level of invasion: An analysis of 539 cases. Cancer 59:682-687, 1987.
89. Noguchi M, Ohta N, Thomas M, et al.: Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer. Surg Oncol 2:51-58, 1993.
90. Noguchi M, Miyazaki I: Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat (in press).
91. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 81:1615-1616, 1994.
92. Davies GC, Millis RR, Hayward JL: Assessment of axillary lymph node status. Ann Surg 192:148-151, 1980.
93. Adami HO, Graffman S, Johansson H, et al.: Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer 38:624-630, 1978.
94. Fisher CJ, Boyle S, Burke M, et al.: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80:457-458, 1993.
95. Kissin MW, Price AP, Thompson EM, et al.: The inadequacy of axillary sampling in breast cancer. Lancet 1:1210-1212, 1982.
96. Steele RJC, Forrest APM, Gibson T, et al.: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: A controlled randomized trial. Br J Surg 72:368-369, 1985.
97. Forrest AP, Stewart HJ, Roberts MM, et al.: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196:371-378, 1982.
98. Noguchi M, Minami M, Earashi M, et al.: Intraoperative assessment of axillary lymph node metastases in operable breast cancer. Breast Cancer Res Treat (in press).
99. Guiliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994.
100. Guiliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222:394-401, 1995.
101. Silverstein MJ, Rosser RJ, Gierson ED, et al.: Axillary lymph node dissection for intraductal breast carcinoma - Is it indicated? Cancer 59:1819-1824, 1987.
102. Silverstein MJ, Gierson ED, Waisman JR, et al.: Axillary lymph node dissection for T1a breast carcinoma. Cancer 73:664-667, 1994.
103. Lagios MD, Westdahl PR, Margolin FR, et al.: Duct carcinoma in situ, Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50:1309-1314, 1982.
104. Carter D, Smith RL: Carcinoma in situ of the breast. Cancer 40:1189-1193, 1977.
105. Haffty BG, McKhann C, Beinfield M, et al.: Breast conservation therapy without axillary dissection. Arch Surg 128:1315-1319, 1993.
106. Noguchi M, Miyazaki I: Prognostic factors in breast cancer and their controversies (review). Oncol Rep 1:1157-1163, 1994.
107. Balch CM, Singletary SE, Bland KI: Clinical decision-making in early breast cancer. Ann Surg 217:207-225, 1993.